Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 385

1.

Critical Consideration of Myxedema Coma in the Postoperative Setting: A Case Report.

Tran M, Vincent L, Ho G, Kelly K, Bouvet M, Meier A.

A A Pract. 2018 Aug 29. doi: 10.1213/XAA.0000000000000864. [Epub ahead of print]

PMID:
30169383
2.

Imaging the interaction of αv integrin-GFP in osteosarcoma cells with RFP-expressing host stromal cells and tumor-scaffold collagen in the primary and metastatic tumor microenvironment.

Tome Y, Kiyuna T, Uehara F, Bouvet M, Tsuchiya H, Kanaya F, Hoffman RM.

J Cell Biochem. 2018 Aug 26. doi: 10.1002/jcb.27353. [Epub ahead of print]

PMID:
30145815
3.

Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.

Lwin TM, Hoffman RM, Bouvet M.

J Surg Oncol. 2018 Aug;118(2):253-264. doi: 10.1002/jso.25150. Epub 2018 Aug 6. Review.

PMID:
30080930
4.

Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations.

Miyake K, Kawaguchi K, Miyake M, Zhao M, Kiyuna T, Igarashi K, Zhang Z, Murakami T, Li Y, Nelson SD, Bouvet M, Elliott I, Russell TA, Singh AS, Hiroshima Y, Momiyama M, Matsuyama R, Chishima T, Singh SR, Endo I, Eilber FC, Hoffman RM.

Heliyon. 2018 Jun 6;4(6):e00643. doi: 10.1016/j.heliyon.2018.e00643. eCollection 2018 Jun.

5.

Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.

Kawaguchi K, Miyake K, Zhao M, Kiyuna T, Igarashi K, Miyake M, Higuchi T, Oshiro H, Bouvet M, Unno M, Hoffman RM.

Cell Cycle. 2018 Sep 19:1-8. doi: 10.1080/15384101.2018.1480223. [Epub ahead of print]

PMID:
29963961
6.

Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer.

Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Kiyuna T, Miyake M, Higuchi T, Oshiro H, Zhang Z, Razmjooei S, Wangsiricharoen S, Bouvet M, Singh SR, Unno M, Hoffman RM.

Cancer Lett. 2018 Sep 28;432:251-259. doi: 10.1016/j.canlet.2018.06.016. Epub 2018 Jun 18.

PMID:
29928962
7.

Expression and Implication of Clusterin in Left Ventricular Remodeling After Myocardial Infarction.

Turkieh A, Fertin M, Bouvet M, Mulder P, Drobecq H, Lemesle G, Lamblin N, de Groote P, Porouchani S, Chwastyniak M, Beseme O, Amouyel P, Mouquet F, Balligand JL, Richard V, Bauters C, Pinet F.

Circ Heart Fail. 2018 Jun;11(6):e004838. doi: 10.1161/CIRCHEARTFAILURE.117.004838.

PMID:
29891738
8.

MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model.

Kawaguchi K, Igarashi K, Miyake K, Lwin TM, Miyake M, Kiyuna T, Hwang HK, Murakami T, Delong JC, Singh SR, Clary B, Bouvet M, Unno M, Hoffman RM.

Tissue Cell. 2018 Jun;52:124-128. doi: 10.1016/j.tice.2018.05.003. Epub 2018 May 5.

PMID:
29857821
9.

The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic.

Lwin TM, Hoffman RM, Bouvet M.

Expert Rev Anticancer Ther. 2018 Jul;18(7):651-662. doi: 10.1080/14737140.2018.1477593. Epub 2018 May 28.

PMID:
29768067
10.

Comprehensive Study of Poly(2,3,5,6-tetrafluoroaniline): From Electrosynthesis to Heterojunctions and Ammonia Sensing.

Mateos M, Meunier-Prest R, Heintz O, Herbst F, Suisse JM, Bouvet M.

ACS Appl Mater Interfaces. 2018 Jun 13;10(23):19974-19986. doi: 10.1021/acsami.8b03601. Epub 2018 May 29.

PMID:
29737156
11.

RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence.

Sato K, Mori R, Hiroshima Y, Oba MS, Matsuyama R, Bouvet M, Hoffman RM, Endo I.

J Surg Res. 2018 Jun;226:122-130. doi: 10.1016/j.jss.2017.11.009. Epub 2018 Feb 22.

PMID:
29661277
12.

Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Lwin TM, Higuchi T, Kiyuna T, Miyake M, Oshiro H, Bouvet M, Unno M, Hoffman RM.

Cell Cycle. 2018;17(7):868-873. doi: 10.1080/15384101.2018.1445907. Epub 2018 May 21.

PMID:
29623758
13.

Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.

Mohapatra SS, Batra SK, Bharadwaj S, Bouvet M, Cosman B, Goel A, Jogunoori W, Kelley MJ, Mishra L, Mishra B, Mohapatra S, Patel B, Pisegna JR, Raufman JP, Rao S, Roy H, Scheuner M, Singh S, Vidyarthi G, White J.

Dig Dis Sci. 2018 May;63(5):1123-1138. doi: 10.1007/s10620-018-5000-0. Epub 2018 Mar 23. Review.

14.

Optical Fibre NO₂ Sensor Based on Lutetium Bisphthalocyanine in a Mesoporous Silica Matrix.

Debliquy M, Lahem D, Bueno-Martinez A, Caucheteur C, Bouvet M, Recloux I, Raskin JP, Olivier MG.

Sensors (Basel). 2018 Mar 1;18(3). pii: E740. doi: 10.3390/s18030740.

15.

Transcriptomic definition of molecular subgroups of small round cell sarcomas.

Watson S, Perrin V, Guillemot D, Reynaud S, Coindre JM, Karanian M, Guinebretière JM, Freneaux P, Le Loarer F, Bouvet M, Galmiche-Rolland L, Larousserie F, Longchampt E, Ranchere-Vince D, Pierron G, Delattre O, Tirode F.

J Pathol. 2018 May;245(1):29-40. doi: 10.1002/path.5053. Epub 2018 Mar 30.

PMID:
29431183
16.

Fluorescence-guided Surgery with Splenic Preservation Prevents Tumor Recurrence in an Orthotopic Nude-mouse Model of Human Pancreatic Cancer.

Hwang HK, Kang CM, Lee SH, Murakami T, Kiyuna T, Kim SH, Hoffman RM, Bouvet M.

Anticancer Res. 2018 Feb;38(2):665-670.

PMID:
29374688
17.

Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.

Lwin TM, Murakami T, Miyake K, Yazaki PJ, Shivley JE, Hoffman RM, Bouvet M.

Ann Surg Oncol. 2018 Apr;25(4):1079-1085. doi: 10.1245/s10434-018-6344-6. Epub 2018 Jan 25.

PMID:
29372363
18.

The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing's sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therapy.

Miyake K, Murakami T, Kiyuna T, Igarashi K, Kawaguchi K, Miyake M, Li Y, Nelson SD, Dry SM, Bouvet M, Elliott IA, Russell TA, Singh AS, Eckardt MA, Hiroshima Y, Momiyama M, Matsuyama R, Chishima T, Endo I, Eilber FC, Hoffman RM.

Oncotarget. 2017 Sep 8;8(61):103129-103136. doi: 10.18632/oncotarget.20789. eCollection 2017 Nov 28.

19.

Splenectomy is associated with an aggressive tumor growth pattern and altered host immunity in an orthotopic syngeneic murine pancreatic cancer model.

Hwang HK, Murakami T, Kiyuna T, Kim SH, Lee SH, Kang CM, Hoffman RM, Bouvet M.

Oncotarget. 2017 Sep 28;8(51):88827-88834. doi: 10.18632/oncotarget.21331. eCollection 2017 Oct 24.

20.

Indocyanine green fluorescence-guided parathyroidectomy for primary hyperparathyroidism.

DeLong JC, Ward EP, Lwin TM, Brumund KT, Kelly KJ, Horgan S, Bouvet M.

Surgery. 2018 Feb;163(2):388-392. doi: 10.1016/j.surg.2017.08.018. Epub 2017 Nov 10.

PMID:
29129358
21.

The benefits and limitations of robotic assisted transhiatal esophagectomy for esophageal cancer.

DeLong JC, Kelly KJ, Jacobsen GR, Sandler BJ, Horgan S, Bouvet M.

J Vis Surg. 2016 Sep 8;2:156. doi: 10.21037/jovs.2016.09.01. eCollection 2016. Review.

22.

Regarding the applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy.

Lwin TM, Hoffman RM, Bouvet M.

Transl Gastroenterol Hepatol. 2017 Sep 12;2:70. doi: 10.21037/tgh.2017.08.09. eCollection 2017. No abstract available.

23.

Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.

DeLong JC, Murakami T, Yazaki PJ, Hoffman RM, Bouvet M.

J Surg Res. 2017 Oct;218:139-143. doi: 10.1016/j.jss.2017.05.069.

PMID:
28985840
24.

Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells.

Yaniz-Galende E, Roux M, Nadaud S, Mougenot N, Bouvet M, Claude O, Lebreton G, Blanc C, Pinet F, Atassi F, Perret C, Dierick F, Dussaud S, Leprince P, Trégouët DA, Marazzi G, Sassoon D, Hulot JS.

J Am Coll Cardiol. 2017 Aug 8;70(6):728-741. doi: 10.1016/j.jacc.2017.06.010.

25.

Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and Metastasis in a Syngeneic Pancreatic-Cancer Orthotopic Mouse Model.

Murakami T, Hiroshima Y, Zhang Y, Zhao M, Kiyuna T, Hwang HK, Miyake K, Homma Y, Mori R, Matsuyama R, Chishima T, Ichikawa Y, Tanaka K, Bouvet M, Endo I, Hoffman RM.

J Cell Biochem. 2018 Jan;119(1):634-639. doi: 10.1002/jcb.26224. Epub 2017 Aug 11.

PMID:
28628234
26.

Neoadjuvant chemoradiotherapy of pancreatic cancer induces a favorable immunogenic tumor microenvironment associated with increased major histocompatibility complex class I-related chain A/B expression.

Murakami T, Homma Y, Matsuyama R, Mori R, Miyake K, Tanaka Y, Den K, Nagashima Y, Nakazawa M, Hiroshima Y, Ueda M, Tanaka K, Hoffman RM, Bouvet M, Endo I.

J Surg Oncol. 2017 Sep;116(3):416-426. doi: 10.1002/jso.24681. Epub 2017 Jun 12.

PMID:
28608409
27.

Humidity-enhanced sub-ppm sensitivity to ammonia of covalently functionalized single-wall carbon nanotube bundle layers.

Rigoni F, Freddi S, Pagliara S, Drera G, Sangaletti L, Suisse JM, Bouvet M, Malovichko AM, Emelianov AV, Bobrinetskiy II.

Nanotechnology. 2017 Jun 23;28(25):255502. doi: 10.1088/1361-6528/aa6da7. Epub 2017 May 31.

PMID:
28561009
28.

MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX).

Kawaguchi K, Igarashi K, Murakami T, Kiyuna T, Lwin TM, Hwang HK, Delong JC, Clary BM, Bouvet M, Unno M, Hoffman RM.

Oncotarget. 2017 Jul 18;8(29):47490-47496. doi: 10.18632/oncotarget.17667.

29.

Improving theranostics in pancreatic cancer.

King J, Bouvet M, Singh G, Williams J.

J Surg Oncol. 2017 Jul;116(1):104-113. doi: 10.1002/jso.24625. Epub 2017 May 17. Review.

30.

Color-coded intravital imaging demonstrates a transforming growth factor-β (TGF-β) antagonist selectively targets stromal cells in a human pancreatic-cancer orthotopic mouse model.

Murakami T, Hiroshima Y, Miyake K, Hwang HK, Kiyuna T, DeLong JC, Lwin TM, Matsuyama R, Mori R, Kumamoto T, Chishima T, Tanaka K, Ichikawa Y, Bouvet M, Endo I, Hoffman RM.

Cell Cycle. 2017 May 19;16(10):1008-1014. doi: 10.1080/15384101.2017.1315489. Epub 2017 Apr 25.

31.

Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection.

Tummers WS, Warram JM, Tipirneni KE, Fengler J, Jacobs P, Shankar L, Henderson L, Ballard B, Pogue BW, Weichert JP, Bouvet M, Sorger J, Contag CH, Frangioni JV, Tweedle MF, Basilion JP, Gambhir SS, Rosenthal EL.

Cancer Res. 2017 May 1;77(9):2197-2206. doi: 10.1158/0008-5472.CAN-16-3217. Epub 2017 Apr 20. Erratum in: Cancer Res. 2018 Feb 15;78(4):1123.

32.

Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.

Murakami T, Li S, Han Q, Tan Y, Kiyuna T, Igarashi K, Kawaguchi K, Hwang HK, Miyake K, Singh AS, Nelson SD, Dry SM, Li Y, Hiroshima Y, Lwin TM, DeLong JC, Chishima T, Tanaka K, Bouvet M, Endo I, Eilber FC, Hoffman RM.

Oncotarget. 2017 May 30;8(22):35630-35638. doi: 10.18632/oncotarget.15823.

33.

eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth.

Strnadel J, Choi S, Fujimura K, Wang H, Zhang W, Wyse M, Wright T, Gross E, Peinado C, Park HW, Bui J, Kelber J, Bouvet M, Guan KL, Klemke RL.

Cancer Res. 2017 Apr 15;77(8):1997-2007. doi: 10.1158/0008-5472.CAN-16-2594. Epub 2017 Apr 5.

34.

The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago.

Murakami T, Kiyuna T, Kawaguchi K, Igarashi K, Singh AS, Hiroshima Y, Zhang Y, Zhao M, Miyake K, Nelson SD, Dry SM, Li Y, DeLong JC, Lwin TM, Chishima T, Tanaka K, Bouvet M, Endo I, Eilber FC, Hoffman RM.

Cell Cycle. 2017 Jun 3;16(11):1046-1052. doi: 10.1080/15384101.2017.1304340. Epub 2017 Mar 15.

35.

GFP labeling kinetics of triple-negative human breast cancer by a killer-reporter adenovirus in 3D Gelfoam® histoculture.

Yano S, Takehara K, Miwa S, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

In Vitro Cell Dev Biol Anim. 2017 Jun;53(6):479-482. doi: 10.1007/s11626-017-0133-6. Epub 2017 Feb 23. No abstract available.

PMID:
28233141
36.

High-metastatic triple-negative breast-cancer variants selected in vivo become chemoresistant in vitro.

Yano S, Takehara K, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

In Vitro Cell Dev Biol Anim. 2017 Apr;53(4):285-287. doi: 10.1007/s11626-016-0117-y. Epub 2017 Jan 26. No abstract available.

PMID:
28127701
37.

OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.

Yano S, Takehara K, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

Cancer Gene Ther. 2017 Feb;24(2):45-47. doi: 10.1038/cgt.2016.67. Epub 2017 Jan 20.

PMID:
28106046
38.

Oncologic Procedures Amenable to Fluorescence-guided Surgery.

Tipirneni KE, Warram JM, Moore LS, Prince AC, de Boer E, Jani AH, Wapnir IL, Liao JC, Bouvet M, Behnke NK, Hawn MT, Poultsides GA, Vahrmeijer AL, Carroll WR, Zinn KR, Rosenthal E.

Ann Surg. 2017 Jul;266(1):36-47. doi: 10.1097/SLA.0000000000002127. Review.

PMID:
28045715
39.

Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.

Murakami T, Murata T, Kawaguchi K, Kiyuna T, Igarashi K, Hwang HK, Hiroshima Y, Hozumi C, Komatsu S, Kikuchi T, Lwin TM, Delong JC, Miyake K, Zhang Y, Tanaka K, Bouvet M, Endo I, Hoffman RM.

Anticancer Res. 2017 Jan;37(1):61-65.

40.

Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models.

Yano S, Takehara K, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Fujiwara T, Bouvet M, Hoffman RM.

Anticancer Res. 2017 Jan;37(1):57-60.

PMID:
28011473
41.

In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.

Yano S, Takehara K, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

Anticancer Res. 2016 Dec;36(12):6273-6277.

PMID:
27919946
42.

The disintegrin echistatin in combination with doxorubicin targets high-metastatic human osteosarcoma overexpressing ανβ3 integrin in chick embryo and nude mouse models.

Tome Y, Kimura H, Sugimoto N, Tsuchiya H, Kanaya F, Bouvet M, Hoffman RM.

Oncotarget. 2016 Dec 27;7(52):87031-87036. doi: 10.18632/oncotarget.13497.

43.

Tumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse models.

Yano S, Takehara K, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

Oncotarget. 2016 Dec 20;7(51):85273-85282. doi: 10.18632/oncotarget.13296.

44.

Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.

Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, Moosmann A, Hammerschmidt W.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6467-E6475. Epub 2016 Oct 3.

45.

Patient-derived mouse models of cancer need to be orthotopic in order to evaluate targeted anti-metastatic therapy.

Hiroshima Y, Maawy A, Zhang Y, Zhang N, Murakami T, Chishima T, Tanaka K, Ichikawa Y, Bouvet M, Endo I, Hoffman RM.

Oncotarget. 2016 Nov 1;7(44):71696-71702. doi: 10.18632/oncotarget.12322.

46.

Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.

Hiroshima Y, Lwin TM, Murakami T, Mawy AA, Kuniya T, Chishima T, Endo I, Clary BM, Hoffman RM, Bouvet M.

J Surg Oncol. 2016 Dec;114(8):951-958. doi: 10.1002/jso.24462. Epub 2016 Oct 3.

47.

Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence.

Yano S, Takehara K, Miwa S, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

Oncotarget. 2016 Nov 15;7(46):75635-75647. doi: 10.18632/oncotarget.12314.

48.

High-efficacy targeting of colon-cancer liver metastasis with Salmonella typhimurium A1-R via intra-portal-vein injection in orthotopic nude-mouse models.

Kawaguchi K, Murakami T, Suetsugu A, Kiyuna T, Igarashi K, Hiroshima Y, Zhao M, Zhang Y, Bouvet M, Clary BM, Unno M, Hoffman RM.

Oncotarget. 2017 Mar 21;8(12):19065-19073. doi: 10.18632/oncotarget.12227.

49.

Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample.

Fuchs HF, Harnsberger CR, Broderick RC, Chang DC, Sandler BJ, Jacobsen GR, Bouvet M, Horgan S.

Surg Endosc. 2017 Jun;31(6):2491-2497. doi: 10.1007/s00464-016-5251-9. Epub 2016 Sep 22.

PMID:
27660245
50.

A Mouse Model of Fluorescent Protein-expressing Disseminated Peritoneal Lymphoma for Fluorescence-guided Surgery.

Matsumoto T, Suetsugu A, Hasegawa K, Nakamura M, Shibata Y, Aoki H, Kunisada T, Tsurumi H, Shimizu M, Bouvet M, Hoffman RM.

Anticancer Res. 2016 Sep;36(9):4483-7.

PMID:
27630285

Supplemental Content

Loading ...
Support Center